Clinical response at Week 26, in the strata defined by CRP ≥ 10 mg/L.
In population with CRP ≥ 10 mg/L at baseline; Time to disease progression up to and including Week 26; Proportion of patients with clinical remission at Week 26; Proportion of patients with IBDQ response at Week 26; F-36 sub-scores and change from basel
18 Years and older (Adult, Senior)
September 9, 2005
September 9, 2013
† Study has passed its completion date and status has not been verified in more than two years.